IN January this year, India’s drug regulatory authority, the Drugs Controller General of India, granted emergency use clearance to the locally produced coronavirus vaccine, Covaxin, manufactured by the Hyderabad-based Bharat Biotech. The clearance was granted even as the third stage of the